Clinical Trial Update: Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of the Meningococcal Group A and Group C polysaccharide vaccine co-developed by Sanofi Pasteur and the Lanzhou Institute for use i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Disease

Drugs mentioned

• Meningococcal Group A and C polysaccharide vaccine (Meningococcal polysaccharide vaccine (Groups A and C))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Disease, Meningitis | Phase 4 | Status: COMPLETED | Results posted: 2014-05-08